Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients with Drug-Refractory Hypertrophic Obstructive Cardiomyopathy

Zhou, M., Ta, S., Hahn, R. T., Hsi, D. H., Leon, M. B., Hu, R., Zhang, J., Zuo, L., Li, J., Wang, J., Wang, B., Zhu, X., Liu, J., Han, Y., Li, X., Xu, B., Zhang, L., Hou, L., Han, C., … Liu, L. (2022). Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy. JAMA Cardiology, 7(5), 529. https://doi.org/10.1001/jamacardio.2022.0259
Authors:
Mengyao Zhou
Shengjun Ta
Rebecca T. Hahn
David H. Hsi
Martin B. Leon
Rui Hu
Jun Zhang
Lei Zuo
Jing Li
Jing Wang
Bo Wang
Xiaoli Zhu
Jiani Liu
Yupeng Han
Xiaojuan Li
Bo Xu
Lei Zhang
Lihong Hou
Chao Han
Jincheng Liu
Liwen Liu
Affiliated Authors:
Rebecca T. Hahn
David H. Hsi
Martin B. Leon
Columbia Affiliation:
Subjects:
Cardiomyopathy, Hypertrophic (MeSH)
Pericardial Effusion (MeSH)
Radiofrequency Ablation (MeSH)
Stroke (MeSH)
Diagnosis and Management of Hypertrophic Cardiomyopathy (OpenAlex Topic)
Catheter Ablation of Cardiac Arrhythmias (OpenAlex Topic)
Recommendations for Cardiac Chamber Quantification by Echocardiography (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1001/jamacardio.2022.0259
PMID:
35353129
DOI:
10.1001/jamacardio.2022.0259
Journal:
JAMA Cardiology
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View OpenAlex Record
View PubMed Record
View Web of Science Record

Record Created: